Search clinical trials for: Acalabrutinib
Total 154 results
-
AstraZenecaAcerta Pharma, LLCCompletedPharmacokinetics | BioavailabilityUnited States
-
AstraZenecaParexelCompletedCOVID-19 | Mantle Cell LymphomaGermany
-
Acerta Pharma BVAstraZenecaActive, not recruitingMantle Cell Lymphoma (MCL)United States, Poland, Italy
-
Acerta Pharma BVNational Institutes of Health (NIH)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVAstraZenecaCompletedHepatic Insufficiency | Healthy Subjects | Hepatic ImpairmentUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, United Kingdom, Belgium, Spain, Israel, France
-
AstraZenecaCompletedBioequivalenceUnited States
-
Acerta Pharma BVActive, not recruitingGlioblastoma MultiformeUnited States
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Acerta Pharma BVActive, not recruitingWaldenström Macroglobulinemia (WM)Spain, United States, United Kingdom, France, Italy, Greece, Netherlands
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic Leukemia- Binet Staging SystemSpain
-
Acerta Pharma BVActive, not recruitingMantle Cell Lymphoma (MCL)Belgium, France, United Kingdom, United States, Italy, Poland, Netherlands, Australia, Czechia, Spain
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruitingCLL/SLLNetherlands, Belgium, Denmark
-
Mayur NarkhedeADC Therapeutics S.A.RecruitingChronic Lymphocytic LeukemiaUnited States
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
Acerta Pharma BVAcerta Pharma, LLCCompletedMultiple Myeloma (MM)United States, United Kingdom
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedOvarian CancerUnited States
-
Austin I KimAstraZeneca; Genentech, Inc.Recruiting
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
Universität des SaarlandesAstraZeneca; University of Leipzig; Wuerzburg University Hospital; University Hospital... and other collaboratorsRecruitingDiffuse Large B Cell Lymphoma | Large B-cell LymphomaGermany
-
AstraZenecaAcerta Pharma BVCompleted
-
AstraZenecaAcerta Pharma BVCompletedCOVID-19Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
-
TG Therapeutics, Inc.Terminated
-
AstraZenecaYgheaRecruitingChronic Lymphocytic LeukemiaItaly
-
Acerta Pharma BVWithdrawn
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
Johns Hopkins UniversityAstraZenecaCompleted
-
Weill Medical College of Cornell UniversityAstraZenecaWithdrawnChronic Lymphocytic Leukemia | CLL/SLLUnited States
-
Polish Lymphoma Research GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Adverse Event | Chronic Graft-versus-host-disease | Response RatePoland
-
University of Alabama at BirminghamNot yet recruiting
-
AstraZenecaUKCLL ForumRecruitingChronic Lymphocytic Leukemia, CLLUnited Kingdom
-
Dana-Farber Cancer InstituteRecruitingRefractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
Acerta Pharma BVAstraZenecaTerminated
-
Acerta Pharma BVCompletedHepatic InsufficiencyUnited States
-
Hospital Universitari de BellvitgeCompletedLow Rectal Adenocarcinoma
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingMarginal Zone LymphomaItaly, Switzerland, Austria
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
University Health Network, TorontoActive, not recruiting
-
Nordic Lymphoma GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | MCLFinland, Sweden, Norway, Denmark, Korea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...AstraZenecaRecruitingChronic Lymphocytic LeukemiaChina
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited Kingdom, Poland
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Inhye AhnBayerWithdrawnChronic Lymphocytic Leukemia (CLL)
-
Acerta Pharma BVAstraZenecaActive, not recruitingMultiple Myeloma | Non-Hodgkins Lymphoma | B-AllUnited States
-
Aprea TherapeuticsTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Rigshospitalet, DenmarkKarolinska Institutet; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsRecruitingCLLDenmark, Sweden, Netherlands